Towards Remission and Full Recovery From Obsessive-compulsive Disorder

Recruiting N/A Interventional Study
Obsessive-Compulsive Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
160 (estimated)
Sponsor
Ciusss de L'Est de l'Île de Montréal · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Obsessive-compulsive disorder (OCD) is a disabling psychiatric illness that is characterized by distressing obsessional thoughts and time-consuming compulsive rituals. Exposure and Response Prevention (ERP) is a first-line psychological treatment of choice that requires patients to face their fears by being exposed to feared stimuli. This treatment has been shown to reduce symptoms in a significan…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: 1. a primary diagnosis of OCD according to DSM-5 criteria. 2. a score ≥ 18 on the Y-BOCS 3. age ≥ 18. 4. no change in medication during the 8 weeks before treatment for antidepressants (4 weeks for anxiolytics). 5. willingness to keep medication stable while participating in the…
Contacts

Frederick Aardema, PhD

514-662-5116

faardema@gmail.com

CONTACT

Lysandre Bourguignon, Msc

514-251-3400

lysandre.bourguignon.cemtl@ssss.gouv.qc.ca

CONTACT